NVTA - Invitae Corporation
| Previous Close | 21.14 |
| Open | 21.11 |
| Bid | 21.03 x 800 |
| Ask | 21.63 x 1100 |
| Day's Range | 20.98 - 21.77 |
| 52 Week Range | 9.04 - 28.75 |
| Volume | 1,462,466 |
| Avg. Volume | 2,378,482 |
| Market Cap | 2.06B |
| Beta (3Y Monthly) | 3.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.87 |
| Earnings Date | Feb 12, 2018 - Feb 16, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.54 |
- Zacks
Invitae (NVTA) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Invitae (NVTA) closed at $21.68, marking a -1% move from the previous day.
- PR Newswire
Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
SAN FRANCISCO, Sept. 9, 2019 /PRNewswire/ -- Invitae (NVTA), a leading medical genetics company, today announced the availability of Detect Hereditary Pancreatic Cancer, a testing program that offers no-charge genetic testing and counseling to patients with pancreatic cancer. Genetic testing is recommended by clinicians for all pancreatic cancer patients to guide treatment choices and evaluate eligibility for clinical trials.
- PR Newswire
Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes
SAN FRANCISCO, Sept. 6, 2019 /PRNewswire/ -- Invitae Corporation (NVTA) announced the pricing on September 5, 2019 of $300.0 million aggregate principal amount of 2.00% convertible senior notes due 2024 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The aggregate principal amount of the offering was increased from the previously announced offering size of $200.0 million. Invitae granted the initial purchasers of the notes a 13-day option to purchase up to an additional $50.0 million principal amount of notes on the same terms and conditions.
- PR Newswire
Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes
SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Invitae Corporation (NVTA) today announced its intention to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of convertible senior notes due 2024 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). In connection with the offering, Invitae expects to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $30.0 million principal amount of notes on the same terms and conditions. Invitae intends to use the net proceeds from the offering of the notes to repay, including a prepayment premium, the $75.0 million in aggregate principal amount of notes outstanding under its 2018 Note Purchase Agreement and for international expansion, infrastructure investment, working capital and other general corporate purposes.
- InvestorPlace
4 Top Stock Trades for Wednesday: TWTR, WMT, CLF, NVTA
Tuesday marked the first trading session of September, as well as the first session in the holiday-shortened week, with U.S. equity markets closed on Monday in observance of Labor Day. It wasn't an easy session for traders to get reacquainted with though. Let's look at a few top stock trades. Top Stock Trades for Tomorrow 1: TwitterTwitter (NYSE:TWTR) stock have been moving really well and even on Tuesday, the early price action looked promising. Shares were trying to breakout of an ascending triangle, a bullish setup where rising uptrend support continues to squeeze a stock against a static level of resistance.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Buy for September That resistance came into play around $43. The stock was swiftly rejected from this level while the broader market was under notable pressure.However, uptrend support (blue line) is still holding strong, while the 20-day moving average is just below current levels.If these marks give way, $40 is on the table. A move over $43 could still trigger a breakout, but TWTR needs to close over this level. Top Stock Trades for Tomorrow 2: WalmartWalmart (NYSE:WMT) stock also continues to trade relatively well so far this month. However, the stock continues to struggle with this $114 to $115 level.In the last two months, WMT has found itself in this area on three separate occasions. Each test of $115 comes following a higher low, as highlighted by the purple arrows on the chart above.If the overall market falls apart, it will be harder for WMT stock to breakout. However, shares are sitting right under the trigger spot. A close over $115 could cause an even larger move to the upside, with $120 on many traders' radar.On the downside, I would really like to see the 20-day and 50-day moving averages hold as support. Top Stock Trades for Tomorrow 3: Cleveland-CliffsCleveland Cliffs (NYSE:CLF) is getting hammered on the day, falling about 15% on Tuesday. It's more than just a tough day though, as CLF falls below its 200-week moving average.Should CLF reclaim this area and hold it by Friday's close, bulls can breathe a sigh of relief. However, a close below this mark puts the $6 mark on the table for the struggling stock.Shares were putting in a series of lower highs (blue line) above the $10 mark, and since breaking down over the past few months, CLF has lost almost 50% from its 2019 highs. Down seven weeks in a row has made this one a tough stock to own.Let's see if CLF gets down to $6 and how it responds if it does. From here, investors either need to see CLF reclaim the 200-week or test $6. We'll have a better idea on CLF after that. Top Stock Trades for Tomorrow 4: InvitaeA 2019 favorite of mine, Invitae (NASDAQ:NVTA) has not been trading all that well as of late. Shares gapped up in early August on drastically better-than-expected quarterly results.But as the stock market chopped back and forth, NVTA wasn't able to demonstrate any relative strength. Worse, since that post-earnings gap up shares of Invitae have been under pressure, as downtrend resistance squeezes it lower.With the 50-day moving average turning from support to resistance, NVTA has a true test potentially coming up: Will the $21 to $22 area support the stock? This level was support in March and April before giving way and acting as resistance in May and June. * 7 Best Tech Stocks to Buy Right Now At the end of June, NVTA reclaimed this level and it again served as support. Let's see if it does again. Below it and the 200-day moving average may be on the table.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long NVTA. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Best Tech Stocks to Buy Right Now * 10 Mid-Cap Stocks to Buy * 8 Precious Metals Stocks to Mine For The post 4 Top Stock Trades for Wednesday: TWTR, WMT, CLF, NVTA appeared first on InvestorPlace.
- Thomson Reuters StreetEvents
Edited Transcript of NVTA earnings conference call or presentation 6-Aug-19 8:30pm GMT
Q2 2019 Invitae Corp Earnings Call
- GuruFocus.com
Invitae Corp (NVTA) COO E Lee Bendekgey Sold $537,792 of Shares
COO of Invitae Corp (30-Year Financial, Insider Trades) E Lee Bendekgey (insider trades) sold 21,265 shares of NVTA on 08/19/2019 at an average price of $25.29 a share. Continue reading...
- GlobeNewswire
Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients
SMA Identified program offers genetic testing for SMA at no charge to individuals in the U.S. CAMBRIDGE, Mass. and SAN FRANCISCO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (BIIB) and Invitae Corporation (NVTA) today announced that SMA STAT, a new, rapid-turnaround genetic test for spinal muscular atrophy (SMA), will be offered at no charge to individuals in the U.S. as part of the SMA Identified program. The SMA STAT test reduces the time needed for genetic testing to help confirm a definitive diagnosis of SMA from 21 to four days, enabling individuals and physicians to plan and begin treatment earlier for what is often a life-threatening disease.
- Schaeffer's Investment Research
Citron Favorite Flashes Buy Signal
A short squeeze could also power the shares higher
- Simply Wall St.
Are Insiders Selling Invitae Corporation (NYSE:NVTA) Stock?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
- ETF Trends
Disruptive Health Care ETF Is Good For Your Genes
Reported on by Bloomberg’s Scarlet Fu, take a look at the ARK Genomic Revolution ETF (ARKG) if you are looking for an ETF that goes after companies involved in the genomics industry. Functioning as an ...
- InvestorPlace
5 Top Stock Trades for Thursday: TLT, WW, CVS, NVTA, MU
When volatility picks up, the moves get wild on both ends of the spectrum. In pre-market trading, the markets were set for another nice open, but traders suddenly found U.S. indices down about 1.5% going into the open. By the afternoon, equities were green. Let's look at some top stock trades in that mix. Top Stock Trades for Tomorrow 1: BondsAs you can see in the image above, there has been a flight to U.S. bonds, thus jolting the iShares 20+ Treasury Bond ETF (NASDAQ:TLT) higher by almost 10% in just a few trading sessions. Heck, just look at the volume from the last few days. It's impressive, but looking exhausted.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 3 Steps Every Investor Should Take Before the Next Stock Market Crash Now look at the weekly chart below, looking at the last four years.Notice the orange line up at the top of the chart. This is the RSI, which measures the overbought and oversold condition of a particular security. The TLT has only been this overbought two other times in the past four years. Each other time it's led to a substantial correction.Talk to any semi-seasoned trader though and they'll be quick to point out that the RSI alone is not reason enough to take a trade. But when sentiment is at an extreme and shares begin to act irrational, a temporary high/low may not be far off.Notice how seemingly everyone's become a currency and yield-curve expert over the past week? That's not a coincidence. This week, TLT blew out of its channel, but looks like it could be topping.Look for a check-back down one of three areas: prior channel resistance near $137, the 10-week moving average now at $133 and climbing or range resistance at $133 (black line). Top Stock Trades for Tomorrow 2: MicronMicron (NASDAQ:MU) took a tumble on Wednesday but was at least able to rally off the lows. Between the 20-day and 50-day moving averages now, let's see what's next before jumping in on MU.A further correction could send shares to $39, where it has the 50-day and 200-day moving averages. It also found this level as support in July.On a rally, see if it can reclaim the 20-day moving average. More importantly though, see how it handles the $44 to $45 area, a major zone of resistance in 2019. Over it puts the July highs back on the table. Top Stock Trades for Tomorrow 3: Weight WatchersWeight Watchers (NASDAQ:WW) erupted on Wednesday, climbing some 40% after the company reported earnings. Sheesh!Anyway, longs need to be careful. As if buying a 40% move isn't dangerous enough, WW is running right into its 200-day moving average. It's also hitting short-term channel resistance, although it's possible it breaks out.Over the 200-day sets up a potential rally for more gains, though. If it does, look for a move up to the $34.30 to $35 area. Although not pictured on the daily chart above, that's where WW will run into the 50-week and 200-week moving averages.If the 200-day acts as resistance, see how $25 holds as support on a potential pullback. Top Stock Trades for Tomorrow 4: CVS HealthLike it or not, CVS Health (NYSE:CVS) continues to slowly but surely improve. The stock is erupting more than 7% on strong earnings. Should shares finish strong on the day, it will be a perfect red-to-green candidate.For swing traders and investors, the stock continues to buoy nicely along channel support, making a perfect test just yesterday. Now up over $57, I want to see CVS hold above this zone. However, below $56 and the 20-day moving average may put channel support back in play.Should shares continue higher, look for a test of $60. That's where CVS will find channel resistance and the 200-day moving average. Top Stock Trades for Tomorrow 5: InvitaeInvitae (NASDAQ:NVTA) reported a really great quarter and rose nearly 20% in after-hours and pre-market trading. Those gains did not translate to the regular session though. The stock was up more than 13% at one point, but those gains have been axed in half toward the close. * 10 Stocks to Buy on the Trade War Dip If NVTA can hold up over $25, I'd consider it a positive development. Over Wednesday's high could easily send it to $30 if the broader market is cooperating. Below the 20-day and uptrend support, and NVTA may be headed to the 50-day currently at $22.33.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long NVTA. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy on the Trade War Dip * The 5 Highest-Rated Dow Stocks Right Now * 4 Cybersecurity Stocks to Buy for Long-Term Gains The post 5 Top Stock Trades for Thursday: TLT, WW, CVS, NVTA, MU appeared first on InvestorPlace.
Motley FoolInvitae Corp (NVTA) Q2 2019 Earnings Call Transcript
NVTA earnings call for the period ending June 30, 2019.
- Zacks
Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates
Invitae (NVTA) delivered earnings and revenue surprises of -8.33% and 5.92%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
-- Increased quarterly revenue by 43% and volume by 52% year-over-year -- -- Announced appointment of Sean George as chairman of the Board of Directors, retirement of Randy Scott as executive chairman, ...
- Motley Fool
Here's Why Genetic Testing Stocks Rose as Much as 25.4% in July
It was a great month to be a genetic testing company.
- Zacks
Implied Volatility Surging for Invitae (NVTA) Stock Options
Investors need to pay close attention to Invitae (NVTA) stock based on the movements in the options market lately.
- TheStreet.com
Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts
Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.
- Schaeffer's Investment Research
Citron Thinks This Stock Could Quadruple
A short squeeze could add fuel to the stock's fire
- TheStreet.com
Short Seller Left Goes Long on Invitae With $100 Target
Invitae was trading up 1.4% to $27.56 after the Citron analyst published a note and placed a $100 price target on the stock. The company has an "indestructible moat" around genetic testing, Left wrote. Invitae "has now realized that genetic testing will become a cornerstone of healthcare and has taken a page out of the [Exact Science ] playbook by going direct to consumer with a clinical grade product that requires a clinician," Left said.
- InvestorPlace
5 Top Stock Trades for Wednesday: UAA, PEP, NVTA
While the selloffs aren't enormous, it's clear that investors are getting defensive ahead of the Fed's announcement on Wednesday. Amid the rate-cut drama is a plethora of earnings results. Let's look at a few top stock trades. Top Stock Trades for Tomorrow 1: Under Armour Click to EnlargeUnder Armour (NYSE:UA, NYSE:UAA) stock is getting smacked on earnings, falling over 12% on the day. However, the stock is well off its session lows, as UAA stock bounces from its 200-day moving average and 50% retracement.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Companies I'd Love to See Go Public Now near $24, we find the stock at an interesting juncture. Either shares rally through the significant level of $25 or they fall below $22.If it's the former, it could trigger a rally up to the 50-day moving average at $25.74, and possibly fill the gap up to $27. If it's the latter, it will lose the 200-day moving and 50% retracement. It could open up UAA to a drop to the 61.8% retracement at $20.80. Top Stock Trades for Tomorrow 2: PepsiCo Click to EnlargePresuming that the Fed follows through with a rate cut, it should be good news for equities. Stocks of all kinds -- tech to dividend champions -- should benefit, PepsiCo (NYSE:PEP) included.However, the stock has been trading quite poorly as of late. Shares are struggling to reclaim the 50-day and 20-day moving averages, with the latter crossing below the former and signaling that short-term momentum is turning bearish. Downtrend resistance (blue line) is also forming a series of higher lows.It gives bears a low-risk shorting opportunity.If PEP closes over the $131.50 to $132 area, they can cover their positions. If PEP falls below $130, it opens up the stock to a test of its monthly lows near $128.40. Below that and it could trigger a fall down to the $124 to $125 area. Top Stock Trades for Tomorrow 3: Invitae Click to EnlargeWe've been talking about Invitae (NASDAQ:NVTA) all year long, from its breakout over $15 to the really bullish action throughout the last two months. Can it get to $100 like Citron suggests?Now, shares are hitting new 52-week highs just over $27. If it breaks out, a run into the upper $20s and possibly up to $30 is possible. On the downside, I want to see $25 hold as support. Top Stock Trades for Tomorrow 4: Capital One Click to EnlargeCapital One Financial (NYSE:COF) has been stuck at its lows all session, muddling about as its lower by more than 7% on the day as it discloses a big-time data breach.The price action doesn't bode well for a bounce, particularly as the charts get a bit sloppy from here.$90 has proven significant over the past few years, while the 38.2% retracement for the one-year range is at $89.28. Below this area could trigger a move down to the 50-week moving average at $87.29.The problem with COF stock? While $90 is propping it up, it's below both uptrend support (blue line) and prior downtrend resistance (purple line). The latter has been present for years now, but gave way after last week's massive rally.I would not be a buyer of COF in the short-term unless it reclaims the 10-week moving average and prior downtrend resistance. There are better, more well-defined setups out there than CFO. Top Stock Trades for Tomorrow 5: Pfizer Click to EnlargeNow this one's a curveball. On Monday, Pfizer (NYSE:PFE) announced a merger deal with Mylan (NYSE:MYL), but only saw slight selling pressure on the day. While the selling did pick up into the close, not many were expecting a near-7% decline on Tuesday.The move has PFE stock plunging through its 50-week moving average and well below its 10-week moving average. I don't know if it will get there, but buying PFE at $37 seems somewhat interesting. It'll give PFE a 3.9% dividend yield and bring it back to prior resistance. It will also give bulls a well-defined risk/reward. * 7 Stocks to Buy With Over 20% Upside From Current Levels Should Pfizer firm up before that, let's see if it can reclaim $40 or if this mark acts as resistance.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long NVTA and short PEP. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Small-Cap Stocks to Buy Before They Grow Up * 7 Stocks to Buy With Over 20% Upside From Current Levels * 7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk The post 5 Top Stock Trades for Wednesday: UAA, PEP, NVTA appeared first on InvestorPlace.
- Zacks
Analysts Estimate Invitae (NVTA) to Report a Decline in Earnings: What to Look Out for
Invitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Will Genetic Testing Drive Invitae's (NVTA) Q2 Earnings?
Invitae (NVTA) expects to deliver a strong second quarter, banking on solid performance of its genetic testing business.
